Test DescriptionTop
1. Depending on the device, electrographic (ECG) signals from 2, 3, or less commonly 12 leads are recorded.
2. The patient wears the Holter ECG monitor for 24 to 72 hours and keeps a diary of symptoms (time of occurrence and description) to facilitate the subsequent interpretation of results.
An increasing variety of devices are capable of monitoring the heart rhythm for weeks or months, which is useful in patients with infrequent symptoms. These are patch monitors, which monitor the patient for up to 2 weeks and do not require leads; event (loop) monitors, which are activated by the patient during symptom occurrence and may be used for over a month; or insertable cardiac monitors, which could be used for well over a year.
Result InterpretationTop
1. Sinus rhythm criterion: Positive P waves in lead CM5 (positive electrode over the fifth intercostal space on the left anterior axillary line; negative electrode over the manubrium). Assessment of the less frequently used 12-lead Holter ECG is the same as for standard ECG.
2. Automated assessment of continuous ambulatory ECG recording performed by an automatic analyzer requires the additional verification of:
1) Maximum and minimum sinus rates and maximum and minimum ventricular rates (in patients with atrial fibrillation or flutter).
2) Pauses. Holter systems analyze RR intervals, not PP intervals, and therefore pauses (aside from artifacts) may be caused by dropped P waves and QRS complexes (sinus arrest, sinoatrial block), or dropped QRS complexes only (second-degree or third-degree atrioventricular block).
3) The origin of tachycardia (the analyzer does not distinguish between narrow-QRS and wide-QRS tachycardia) as well as the heart rate, which may be significantly underestimated in ventricular tachycardia (the analyzer may not count all QRS complexes during ventricular tachycardia).
3. Assessment of the clinical significance of the recorded rhythm abnormalities should take into account the severity of arrhythmia, age, as well as type of activity (sleep vs awake) and overall health of the patient. Supraventricular and ventricular arrhythmias may be sometimes present in otherwise healthy individuals (Table 20.2-1).
4. Assessment of ST-segment changes:
1) ST-segment depressions are considered significant if they are horizontal or downsloping, ≥1 mm deep, and lasting ≥1 minute. ST-segment depressions confirm the diagnosis of coronary artery disease in men aged ≥35 years and women >55 years with typical angina. In men ≥35 years with atypical angina, men >55 years with a nonanginal chest pain, and women >45 years with atypical angina, the diagnosis of coronary artery disease established on the basis of ST-segment depressions must be confirmed by imaging studies (perfusion scintigraphy or stress echocardiography).
2) Asymptomatic long-lasting ST-segment elevations during sleep associated with sinus bradycardia and increased T-wave amplitudes are generally caused by increased parasympathetic tone.
3) ST-segment elevations associated with angina or ventricular arrhythmia lasting several minutes at a time and not accompanied by bradycardia are typical of vasospastic (Prinzmetal) angina.
TABLESTop
|
Arrhythmia |
Age |
|||
|
16-30 years |
31-40 years |
41-60 years |
>60 years |
|
|
Sinus bradycardia 40-60/min |
||||
|
Sinus bradycardia 30-40/mina |
|
|
||
|
First-degree AV blocka |
|
|||
|
Second-degree AV block type Ia |
|
|
||
|
R-R pauses <2 seconds |
||||
|
R-R pauses 2-3 secondsa |
|
|
|
|
|
Occasional VPBs (<50/24 h) |
||||
|
Frequent VPBs (100-1000/24 h) |
|
|
|
|
|
VPB pairs |
|
|
|
|
|
Occasional SPBs (50-100/24 h) |
|
|
||
|
Frequent SPBs (100-1000/24 h) |
|
|
|
|
|
Shaded areas represent age groups in which arrhythmia may be interpreted as normal. a During sleep, usually at night. |
||||
|
AV, atrioventricular; SPB, supraventricular premature beat; VPB, ventricular premature beat. |
||||